Immune Checkpoint Inhibitor-Induced Type 1 Diabetes Mellitus

**Semantic type:** Disease or Syndrome

**Definition:** Type I diabetes mellitus secondary to immune checkpoint inhibitor therapy. It is a rare adverse effect that is characterized by the acute onset of severe hyperglycemia due to insulin deficiency.

**Synonyms:** - CIADM - Checkpoint Inhibitor-Associated Autoimmune Diabetes Mellitus